Template:Epiglottitis Antibiotics: Difference between revisions

(Created page with "Coverage targets Streptococcus pneumoniae, Staphylococcus pyogenes, and Haemophilus influenzae, and H. parainfluenzae ====Immunocompetent==== *Ceftriaxone 2gm IV once dail...")
 
 
Line 5: Line 5:
*[[Ampicillin/Sulbactam]] 3g (50mg/kg) IV q 6 hours OR
*[[Ampicillin/Sulbactam]] 3g (50mg/kg) IV q 6 hours OR
*[[Levofloxacin]] 750mg IV once daily
*[[Levofloxacin]] 750mg IV once daily
*Consider [[Vancomycin]] 15-20mg/kg to any of the above if risk of [[MRSA]]<ref>Young LS, Price CS. Complicated adult epiglottitis due to methicillin-resistant Staphylococcus aureus. Am J Otolaryngol. Nov-Dec 2007;28(6):441-3.</ref>
*Consider [[Vancomycin]] 15-20mg/kg IV to any of the above if risk of [[MRSA]]<ref>Young LS, Price CS. Complicated adult epiglottitis due to methicillin-resistant Staphylococcus aureus. Am J Otolaryngol. Nov-Dec 2007;28(6):441-3.</ref>
 
====Immunocompromised====
====Immunocompromised====
Coverage should extend to all of the typical organisms above as well as Pseudomonas, M. tuberculosis, and C. albicans
Coverage should extend to all of the typical organisms above as well as Pseudomonas, M. tuberculosis, and C. albicans
*[[Cefepime]] 2g (50/kg) IV q8 hours AND [[Vancomycin]] 15mg/kg IV q6 hours
*[[Cefepime]] 2g (50/kg) IV q8 hours AND [[Vancomycin]] 15mg/kg IV q6 hours

Latest revision as of 17:21, 23 June 2019

Coverage targets Streptococcus pneumoniae, Staphylococcus pyogenes, and Haemophilus influenzae, and H. parainfluenzae

Immunocompetent

Immunocompromised

Coverage should extend to all of the typical organisms above as well as Pseudomonas, M. tuberculosis, and C. albicans

  1. Young LS, Price CS. Complicated adult epiglottitis due to methicillin-resistant Staphylococcus aureus. Am J Otolaryngol. Nov-Dec 2007;28(6):441-3.